Insulin resistance and Alzheimer's disease

De La Monte, Suzanne M.·2009·BMB Reports

DOI 10.5483/bmbrep.2009.42.8.475

Cited by (392)

Items 101–200 of 392

Alterations in Hippocampal Oxidative Stress, Expression of AMPA Receptor GluR2 Subunit and Associated Spatial Memory Loss by Bacopa monnieri Extract (CDRI-08) in Streptozotocin-Induced Diabetes Mellitus Type 2 Mice
Pandey, Surya P., Singh, Hemant K., Prasad, S. · 2015 · PLOS ONE
Food reward functions as affected by obesity and bariatric surgery
Andrew Changhun Shin, Hans Rudolf Berthoud · 2011 · International Journal of Obesity
Cognitive dysfunction profile and arterial stiffness in type 2 diabetes
Shima Mehrabian, Margarita Radoslavova Raycheva, Antoaneta Gateva, Gergana Todorova, Petia Angelova, Martina Traykova, Tonya Stankova, Zdravko Asenov Kamenov, Latchezar Dintchov Traykov · 2012 · Journal of the Neurological Sciences
Understanding zebrafish cognition
Дарья Андреевна Мешалкина, Marina N. Kizlyk, Elana V. Kysil, Adam D. Collier, David J. Echevarria, Murilo S. de Abreu, Leonardo José Gil Barcellos, Cai Song, Allan V. Kalueff · 2016 · Behavioural Processes
Increases in β-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-κB pathway activation
Zhiyou Cai, Yu Zhao, Shengtao Yao, Bin Zhao · 2011 · Pharmacological Reports
A preclinical perspective on the enhanced vulnerability to Alzheimer's disease after early-life stress
Lianne Hoeijmakers, Sylvie L. Lesuis, Harm J. Krugers, Paul John Lucassen, Anikó Kőrösi · 2018 · Neurobiology of Stress
Reversal of Metabolic Deficits by Lipoic Acid in a Triple Transgenic Mouse Model of Alzheimer's Disease: A 13C NMR Study
H. Sancheti, K. Kanamori, Ishan Patil, Roberta Diaz-Brinton, B. Ross, E. Cadenas · 2014 · Journal of Cerebral Blood Flow and Metabolism
Overexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer’s disease
Archontia Kaminari, Nikolas Giannakas, Athina K. Tzinia, Effie C. Tsilibary · 2017 · Scientific Reports
Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPKSer-485 Phosphorylation
Bhumsoo Kim, Claudia Figueroa‐Romero, Crystal M. Pacut, Carey Backus, Eva L. Feldman · 2015 · Journal of Biological Chemistry
Metabolic syndrome as a risk factor for Alzheimer's disease: Is Aβ a crucial factor in both pathologies?
Campos-Peña, Victoria, Toral-Rios, Danira, Becerril-Pérez, Fernando, Sánchez-Torres, Carmen, Delgado-Namorado, Yair, Torres-Ossorio, Elimar, Franco-Bocanegra, Diana, Carvajal, Karla · 2017 · Antioxidants & Redox Signaling
Insulin Resistance in Brain and Possible Therapeutic Approaches
Şevki Çetinkalp, Ilgin Yildirim Simsir, Sibel Ertek · 2014 · Current Vascular Pharmacology
Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study
Joakim Hertze, Katarina Nägga, Lennart Minthon, Oskar Hansson · 2014 · BMC Neurology
Traumatic brain injury and obesity induce persistent central insulin resistance
Kate Karelina, Benjamin A. Sarac, Lindsey M. Freeman, Kristopher R. Gaier, Zachary M. Weil · 2016 · European Journal of Neuroscience
mTORC2 (Rictor) in Alzheimer’s Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons
Lee, Han-Kyu, Kwon, Bumsup, Lemere, Cynthia A., de la Monte, Suzanne, Itamura, Kyohei, Ha, Austin Y., Querfurth, Henry W. · 2017 · Journal of Alzheimer's Disease
Protective effect of valproic acid in streptozotocin-induced sporadic Alzheimer’s disease mouse model: possible involvement of the cholinergic system
Mirna Ezzat Sedrak Sorial, Nesrine S. El Sayed · 2017 · Naunyn-Schmiedeberg s Archives of Pharmacology
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease
Nidhi Krishan Sharma, Antonella Tramutola, Chiara Lanzillotta, Andrea Arena, Carla Blarzino, Tommaso Cassano, David Allan Butterfield, Fabio Di Domenico, Marzia Perluigi A, Eugenio Barone · 2019 · Neurobiology of Disease
Early-Stage Alzheimer’s Disease Is Associated with Simultaneous Systemic and Central Nervous System Dysregulation of Insulin-Linked Metabolic Pathways
Suzanne M. de la Monte, Ming Tong, Lori A. Daiello, Brian R. Ott · 2019 · Journal of Alzheimer s Disease
High-sugar diets, type 2 diabetes and Alzheimerʼs disease
Paula Isabel Moreira · 2013 · Current Opinion in Clinical Nutrition & Metabolic Care
Anti-diabetic and anti-Alzheimer’s disease activities of Angelica decursiva
Md Yousof Ali, Hyun Ah Jung, Jae Sue Choi · 2015 · Archives of Pharmacal Research
Insulin receptor substrate 2 is a negative regulator of memory formation
Elaine E. Irvine, Laura Drinkwater, Kasia Radwańska, Hind Al‐Qassab, Mark A. Smith, Melissa S. O’Brien, Catherine Kielar, Agharul I. Choudhury, Stefan Johannes Karl Krauss, Jonathan D. Cooper et al. · 2011 · Learning & Memory
An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer’s Disease
Stanley D. Chamberlain, Hoda Gabriel, Warren J. Strittmatter, John R. Didsbury · 2019 · Journal of Alzheimer s Disease
AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice
Mayuri Khandelwal, Kapil Manglani, Prabhat Upadhyay, Mohammad Azad, Sarika Gupta · 2022 · Neurobiology of Disease
Synthesis, biological activity and structure–activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells
Rosaria Ottanà, Rosanna Maccari, Jérémie Mortier, Anna Caselli, Simona Amuso, Guido Camici, Archimede Rotondo, Gerhard Wolber, Paolo Paoli · 2013 · European Journal of Medicinal Chemistry
Alzheimer's Disease Promotion by Obesity: Induced Mechanisms—Molecular Links and Perspectives
Rita Businaro, Flora Ippoliti, Serafino Ricci, Nicoletta Canitano, Andrea Fuso · 2012 · Current Gerontology and Geriatrics Research
T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer’s Disease
Ming Tong, Chetram Deochand, John R. Didsbury, Suzanne M. de la Monte · 2016 · Journal of Alzheimer s Disease
Insulin resistance is associated with poor functional outcome after acute ischemic stroke in non-diabetic patients
Yoonkyung Chang, Chi Kyung Kim, Minkyung Kim, Woo‐Keun Seo, Kyungmi Oh · 2021 · Scientific Reports
Type 2 Diabetes Mellitus: A Potentially Modifiable Risk Factor for Neurochemical Brain Changes in Bipolar Disorders
Tomáš Hájek, Cynthia Calkin, Ryan Andrew Blagdon, Claire Slaney, Martin Alda · 2013 · Biological Psychiatry
Withaferin A-stimulated Ca2+ entry, ceramide formation and suicidal death of erythrocytes
Kashif Jilani, Adrian Lupescu, Mohanad Zbidah, Nazneen Shaik, Florian J.W. Lang · 2012 · Toxicology in Vitro
Increased risk of cognitive impairment in patients with components of metabolic syndrome
Chia‐Kuang Tsai, Tung‐Wei Kao, Jiunn‐Tay Lee, Chen‐Jung Wu, Dueng‐Yuan Hueng, Chih‐Sung Liang, Gia-Chi Wang, Fu‐Chi Yang, Wei‐Liang Chen · 2016 · Medicine
Elevated CLOCK and BMAL1 contribute to the impairment of aerobic glycolysis from astrocytes in Alzheimer's disease
Yoo, Ik Dong, Park, Min Woo, Cha, Hyeon Woo, Yoon, Sunmi, Boonpraman, Napissara, Yi, Sun Shin, Moon, Jong-Seok · 2020 · International Journal of Molecular Sciences
Insulin resistance and bioenergetic manifestations: Targets and approaches in Alzheimer's disease
Vivek Sharma, Thakur Gurjeet Singh · 2020 · Life Sciences
Cerebrospinal Fluid Aβ42 Levels: When Physiological Become Pathological State
Alessandro Martorana, Francesco Di Lorenzo, Lorena Belli, Giuseppe Sancesario, Sofia Toniolo, Fabrizio Sallustio, Giulia Maria Sancesario, Giacomo Koch · 2015 · CNS Neuroscience & Therapeutics
Non-Demented Individuals with Alzheimer's Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies
Zolochevska, Olga, Taglialatela, Giulio · 2016 · Current Pharmaceutical Design
Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease
Ana Isabel Duarte, Maria S. Santos, Catarina Resende Oliveira, Paula Isabel Moreira · 2018 · Neuropharmacology
Diabetes–Alzheimer's Disease Link: Targeting Mitochondrial Dysfunction and Redox Imbalance
Cristina Carvalho, Susana Cardoso · 2020 · Antioxidants and Redox Signaling
A Possible Link of Gut Microbiota Alteration in Type 2 Diabetes and Alzheimer’s Disease Pathogenicity: An Update
Alam, Mohammad, Alam, Qamre, Kamal, Mohammad, Abuzenadah, Adel, Haque, Absarul · 2014 · CNS & Neurological Disorders - Drug Targets
Stimulation of suicidal death of erythrocytes by rifampicin
Majed Abed, Syeda Tasneem Towhid, Nazneen Shaik, Florian J.W. Lang · 2012 · Toxicology
Physical exercise promotes memory capability by enhancing hippocampal mitochondrial functions and inhibiting apoptosis in obesity-induced insulin resistance by high fat diet
Hye-Sang Park, Han-Sam Cho, Tae-Woon Kim · 2017 · Metabolic Brain Disease
Intranasal metformin treatment ameliorates cognitive functions via insulin signaling pathway in ICV-STZ-induced mice model of Alzheimer's disease
İnci Kazkayası, Gökçen Telli, Emirhan Nemutlu, Serdar Uma · 2022 · Life Sciences
P300 auditory event-related potentials in children with obesity: is childhood obesity related to impairment in cognitive functions?
Mehmet Emre Taşçılar, Doğa Türkkahraman, Oğuzhan Öz, Mehmet Yücel, Mustafa Taşkesen, İbrahim Eker, Ayhan Abacı, Ruşen Dündaröz, Ümit Hıdır Ulaş · 2011 · Pediatric Diabetes
Alzheimer's disease: brain expression of a metabolic disorder?
Sara Merlo, Simona Federica Spampinato, Pier Luigi Canonico, Agata Copani, Maria Angela Sortino · 2010 · Trends in Endocrinology and Metabolism
A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer’s disease, and their co-morbidities
Yun Pan, Jieying Li, Panjie Lin, Lihua Wan, Yiqian Qu, Lingyong Cao, Lei Wang · 2024 · Frontiers in Pharmacology
Alzheimer’s Disease And Type 2 Diabetes: Exploring The Association To Obesity And Tyrosine Hydroxylase
Medha Priyadarshini, Mohammad Amjad Kamal, Nigel H. Greig, Marcella Reale, Adel Mohammed Abuzenadah, Adeel Chaudhary, Ghazi A. Damanhouri · 2012 · CNS & Neurological Disorders - Drug Targets
Biomarkers of Alzheimer Disease, Insulin Resistance, and Obesity in Childhood
R. Luciano, Gloria Maria Barraco, Maurizio Muraca, Simonetta Ottino, M. R. Spreghini, Rita Wietrzykowska Sforza, Carmela Rustico, Giuseppe Stefano Morino, Melania Manco · 2015 · PEDIATRICS
Endoplasmic Reticulum Stress Impairs Insulin Signaling through Mitochondrial Damage in SH-SY5Y Cells
Hyun-Jung Koo, Ying Piao, Youngmi Kim Pak · 2012 · Neurosignals
Brain and behavioral perturbations in rats following Western diet access
Sara L. Hargrave, Terry L. Davidson, Tien-Jui Lee, Kimberly P. Kinzig · 2015 · Appetite
Targeting Alzheimer's Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Dise ase Pathologies
Ming Tong, Cesar Dominguez · 2016 · Journal of Alzheimer’s Disease & Parkinsonism
Metabolic Stress Alters Antioxidant Systems, Suppresses the Adiponectin Receptor 1 and Induces Alzheimer’s Like Pathology in Mice Brain
Jong Ryeal Hahm, Myeung Hoon Jo, Rahat Ullah, Min Woo Kim, Myeong Ok Kim · 2020 · Cells
Unraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators?
Peter S. Spencer, Rebecca C. Fry, Glen E. Kisby · 2012 · Frontiers in Genetics
Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model
Chuang Guo, Shuai Zhang, Jiayi Li, Chen Ding, Zhaohui Yang, Rui Chai, Xu Wang, Zhan‐You Wang · 2016 · Scientific Reports
The Beneficial Role of Vitamin D in Alzheimer’s Disease
Khanh vinh quốc Lương, Lan Nguyễn · 2011 · American Journal of Alzheimer s Disease & Other Dementias®
Executive functions in patients with Alzheimer's disease, type 2 diabetes mellitus patients and cognitively healthy older adults
Maria Redondo, José Luís Beltrán-Brotóns, José Manuel Reales Avilés, Soledad Ballesteros · 2016 · Experimental Gerontology
Brain-Defective Insulin Signaling Is Associated to Late Cognitive Impairment in Post-Septic Mice
Fernanda Neves, Patrícia T. Marques, Fernanda G. Q. Barros‐Aragão, José Bruno Nunes, Aline M. Venancio, Danielle Cozachenco, Rudimar Luiz Frozza, Giselle Fazzioni Passos, Robson da Costa, Jade de Oliveira et al. · 2016 · Molecular Neurobiology
Sweet Taste Receptor Signaling Network: Possible Implication for Cognitive Functioning
Menizibeya Osain Welcome, Nikos E. Mastorakis, Vladimir A. Pereverzev · 2015 · Neurology Research International
Adiponectin and sporadic Alzheimer’s disease: Clinical and molecular links
Liliana Letra, Tiago Rodrigues, Paulo N. Matafome, Isabel J. Santana, Raquel Maria Fino Seiça · 2017 · Frontiers in Neuroendocrinology
Pharmacological Interventions to Attenuate Alzheimer’s Disease Progression: The Story So Far
Firas H. Bazzari, Dalaal M. Abdallah, Hanan Salah El-Abhar · 2019 · Current Alzheimer Research
A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders
Maddie Perdoncin, Alec Konrad, Joshua R. Wyner, Samir Lohana, Sneha S. Pillai, Duane G. Pereira, Hari Vishal Lakhani, Komal Sodhi · 2021 · Frontiers in Molecular Neuroscience
Modulatory effects of vitamin E, acetyl-l-carnitine and α-lipoic acid on new potential biomarkers for Alzheimer's disease in rat model
Hanaa Hamdy Ahmed · 2010 · Experimental and Toxicologic Pathology
Curcumin Ameliorates the Impaired Insulin Signaling Involved in the Pathogenesis of Alzheimer’s Disease in Rats
Tushar Kanti Das, Swarup Kumar Chakrabarti, Ihsan Nazurah Zulkipli, Mas R.W. Abdul Hamid · 2019 · Journal of Alzheimer s Disease Reports
Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases
Chisato Kinoshita, Noriko Kubota, Koji Aoyama · 2021 · International Journal of Molecular Sciences
Potential Role of Akkermansia muciniphila in Parkinson’s Disease and Other Neurological/Autoimmune Diseases
Xin Fang, Fangjun Li, Daojun Hong · 2021 · Current Medical Science
Enhanced Ca2+Entry, Ceramide Formation, and Apoptotic Death of Erythrocytes Triggered by Plumbagin
Adrian Lupescu, Kashif Jilani, Mohanad Zbidah, Elisabeth Lang, Florian J.W. Lang · 2012 · Journal of Natural Products
Linking Alzheimer’s Disease and Type 2 Diabetes Mellitus via Aberrant Insulin Signaling and Inflammation
Mohammad Amjad Kamal, Shubha Priyamvada, Arivarasu Natarajan Anbazhagan, Nasimudeen R. Jabir, Shams S. M. Tabrez, Nigel H. Greig · 2014 · CNS & Neurological Disorders - Drug Targets
Angiotensin II, a neuropeptide at the frontier between endocrinology and neuroscience: is there a link between the angiotensin II type 2 receptor and Alzheimer’s disease?
Nicole Gallo‐Payet · 2011 · Frontiers in Endocrinology
Latest Perspectives on Alzheimer’s Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems
Bianca Sânziana Daraban, Andrei Sabin Popa, Miruna Silvia Stan · 2024 · Molecules
Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimers Disease
Leila Arab, Ramin Sadeghi, Douglas G. Walker, L-F Lue, Marwan Noel Sabbagh · 2011 · Current Neuropharmacology
Testosterone deficiency, insulin-resistant obesity and cognitive function
Hiranya Pintana, Nipon Chattipakorn, Siriporn Chaisin Chattipakorn · 2015 · Metabolic Brain Disease
Plasma Clusterin as a Potential Link Between Diabetes and Alzheimer Disease
Jung-Hee Ha, Min Kyong Moon, Hyunjeong Kim, Minsun Park, So Yeon Cho, Jimin Lee, Jun‐Young Lee, Eosu Kim · 2020 · The Journal of Clinical Endocrinology & Metabolism
Perilla Seed Oil Alleviates Gut Dysbiosis, Intestinal Inflammation and Metabolic Disturbance in Obese-Insulin-Resistant Rats
Napapan Kangwan, Wasana Pratchayasakul, Aphisek Kongkaew, Komsak Pintha, Nipon Chattipakorn, Siriporn Chaisin Chattipakorn · 2021 · Nutrients
Streptozotocin Impairs Proliferation and Differentiation of Adult Hippocampal Neural Stem Cells in Vitro-Correlation With Alterations in the Expression of Proteins Associated With the Insulin System
Ping Sun, Gabriela Ortega, Yan Ming Tan, Qian Hua, Peter Franz Riederer, Jürgen Deckert, Angelika G. Schmitt-Böhrer · 2018 · Frontiers in Aging Neuroscience
Shared signaling pathways in Alzheimer’s and metabolic disease may point to new treatment approaches
Jahnavi Suresh, Ing Wei Khor, Prameet Kaur, Hui Li Heng, Federico Tesio Torta, Gavin Stewart Dawe, E Shyong Tai, Nicholas S. Tolwinski · 2020 · FEBS Journal
Using polyphenols as a relevant therapy to diabetes and its complications, a review
José João Caires Serina, Paula C. Castilho · 2021 · Critical Reviews in Food Science and Nutrition
Calpain Determines the Propensity of Adult Hippocampal Neural Stem Cells to Autophagic Cell Death Following Insulin Withdrawal
Kyung Min Chung, HyunHee Park, Seonghee Jung, Shinwon Ha, Seung‐Jun Yoo, Hanwoong Woo, Hyang Ju Lee, Seong Who Kim, Eun Kyoung Kim, Cheil Moon et al. · 2015 · Stem Cells
α7nAChR activation protects against oxidative stress, neuroinflammation and central insulin resistance in ICV-STZ induced sporadic Alzheimer's disease
P. Yamini, R. S. Ray, Sonal Yadav, Jatinder Dhaliwal, Manisha Yadav, Kanthi Kiran Kondepudi, Kanwaljit Chopra · 2022 · Pharmacology Biochemistry and Behavior
Common Signaling Pathways Involved in Alzheimer’s Disease and Stroke: Two Faces of the Same Coin
Tushar Kanti Das, Bhanu Priya Ganesh, Kaneez Fatima-Shad · 2023 · Journal of Alzheimer s Disease Reports
The role of endoplasmic reticulum stress in hippocampal insulin resistance
Catrina Sims‐Robinson, Anna Bakeman, Rebecca Glasser, Janet M. Boggs, Crystal M. Pacut, Eva L. Feldman · 2016 · Experimental Neurology
Association of metabolic dysfunction with cognitive decline and Alzheimer's disease: A review of metabolomic evidence
Meysam Amidfar, Gholamreza Askari, Yong‐Ku Kim · 2023 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?
Tyler A. Kokjohn, Chera L. Maarouf, Alex E. Roher · 2011 · Alzheimer s & Dementia
A metabolic perspective of late onset Alzheimer’s disease
Miren Ettcheto, Amanda C. Cano, Oriol Busquets, Patrícia Regina Manzine, Elena Sánchez‐López, Ruben Dario Castro-Torres, Carlos Beas‐Zárate, Ester Verdaguer, Maria Luisa García, Jordi Olloquequi et al. · 2019 · Pharmacological Research
Insulin resistance in Alzheimer disease: Is heme oxygenase-1 an Achille's heel?
Eugenio Barone, David Allan Butterfield · 2015 · Neurobiology of Disease
Dementia, stroke and migraine — Some common pathological mechanisms
Katalin Sas, Árpád Párdutz, József Toldi, László Vécsei · 2010 · Journal of the Neurological Sciences
C. elegans insulin-like peptides
Rain Zhu, Ian D. Chin-Sang · 2024 · Molecular and Cellular Endocrinology
Long-Lasting Exendin-4 Fusion Protein Improves Memory Deficits in High-Fat Diet/Streptozotocin-Induced Diabetic Mice
Kyung-Ah Park, Zhen Hua Jin, Jong Youl Lee, Hyeong Seok An, Eun Bee Choi, Kyung Eun Kim, Hyun Joo Shin, Eun Ae Jeong, Kyoung Ah Min, Meong Cheol Shin et al. · 2020 · Pharmaceutics
PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders
Stefanie Saenger, Celia Goeldner, Johann Rudolf Frey, Laurence Ozmen, Susanne Ostrowitzki, Will P. J. M. Spooren, Theresa M. Ballard, E. P. M. Prinssen, Edilio Borroni, Friedrich Metzger · 2011 · Growth Hormone & IGF Research
The Effect of Insulin Infusion on the Metabolites in Cerebral Tissues Assessed With Proton Magnetic Resonance Spectroscopy in Young Healthy Subjects With High and Low Insulin Sensitivity
Monika Karczewska‐Kupczewska, Eugeniusz Tarasów, Agnieszka Nikołajuk, Magdalena Stefanowicz, Natalia Matulewicz, Elżbieta Otziomek, Maria Górska, Marek Strączkowski, Irina Kowalska · 2013 · Diabetes Care
Altered expression of insulin‐degrading enzyme and regulator of calcineurin in the rat intracerebral streptozotocin model and human apolipoprotein E‐ε4–associated Alzheimer's disease
Büşra Delikkaya, Natalia Moriel, Ming Tong, Gina M. Gallucci, Suzanne M. de la Monte · 2019 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
Canine Geriatric Syndrome: A Framework for Advancing Research in Veterinary Geroscience
Brennen A. McKenzie, Frances L. Chen, Margaret E. Gruen, Natasha J. Olby · 2022 · Frontiers in Veterinary Science
Carbohydrates for improving the cognitive performance of independent-living older adults with normal cognition or mild cognitive impairment
Cheow Peng Ooi, Seng Cheong Loke, Zaitun Yassin, Tengku-Aizan Hamid · 2011 · Cochrane Database of Systematic Reviews
Hormonal Signaling Systems of the Brain in Diabetes Mellitus
Alexander Olegovich Shpakov, Oksana V. Chistyakova, Kira Viktorovna Derkach, Vera Bondarev · 2011 · InTech eBooks
Insulin deficiency results in reversible protein kinase A activation and tau phosphorylation
Judith M. van der Harg, Leslie Eggels, Fabian N. Bangel, Silvie R. Ruigrok, Rob Zwart, Jeroen J.M. Hoozemans, Susanne Eva la Fleur, Wiep Scheper · 2017 · Neurobiology of Disease
Insulin Resistance Disrupts the Interaction Between AKT and the NMDA Receptor and the Inactivation of the CaMKIV/CREB Pathway in Minimal Hepatic Encephalopathy
Saidan Ding, Weishan Zhuge, Jianjing Yang, Fangfang Wen, Zhu Xu, Xuebao Wang, Qichuan Zhuge · 2017 · Toxicological Sciences
Function of insulin in snail brain in associative learning
Satoshi Kojima, Hiroshi Sunada, K. Mita, Manabu Sakakibara, Ken D. Lukowiak, Etsuro Ito · 2015 · Journal of Comparative Physiology A
p66Shc Signaling Mediates Diabetes-Related Cognitive Decline
Yohei Minami, Noriyuki Sonoda, Eiichi Hayashida, Hiroaki Makimura, Makoto Ide, Noriko Ikeda, Masahiro Ohgidani, Takahiro A. Kato, Yoshihiro Seki, Yasutaka Maeda et al. · 2018 · Scientific Reports
Stimulation of Insulin Signaling and Inhibition of JNK-AP1 Activation Protect Cells from Amyloid-β-Induced Signaling Dysregulation and Inflammatory Response
Michelle Bamji‐Mirza, Debbie Callaghan, Dema Najem, Shanshan Shen, Mohamed S. Hasim, Ze Yang, Wandong Zhang · 2014 · Journal of Alzheimer s Disease
DPP4 Inhibitors Can Be a Drug of Choice for Type 3 Diabetes: A Mini Review
Nehru Sai Suresh Chalichem, Chaitanya Gonugunta, Praveen Thaggikuppe Krishnamurthy, Duraiswamy Basavan · 2017 · American Journal of Alzheimer s Disease & Other Dementias®
The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates High-fat Induced Cognitive Decline in Tauopathy Model Mice
Yuriko Nakaoku, Satoshi Saitô, Yumi Yamamoto, Takakuni Maki, Ryōsuke Takahashi, Masafumi Ihara · 2019 · International Journal of Molecular Sciences
Reprint of: ‘Brain insulin signaling: A key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes’
Ewan C. McNay, Andrew K. Recknagel · 2011 · Neurobiology of Learning and Memory
Targeting Common Signaling Pathways for the Treatment of Stroke and Alzheimer’s: a Comprehensive Review
Sedigheh Eskandari, Soraya Sajadimajd, Loghman Alaei, Zhaleh Soheilikhah, Hossein Derakhshankhah, Gholamreza Bahrami · 2021 · Neurotoxicity Research
ReCODE: A Personalized, Targeted, Multi-Factorial Therapeutic Program for Reversal of Cognitive Decline
Rammohan V. Rao, Sharanya Kumar, Julie Gregory, Christine Coward, Sho Okada, William Lipa, Lance Kelly, Dale E. Bredesen · 2021 · Biomedicines
Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease
María F. Colavitta, Francisco José Barrantes · 2023 · Pharmaceutics